期刊文献+

心内科患者耐万古霉素金黄色葡萄球菌血流感染的临床分析 被引量:4

Clinical analysis of vancomycin-resistant Staphylococcus aureus infection in patients of cardiology department
原文传递
导出
摘要 目的探讨分析异质性万古霉素中介金黄色葡萄球菌(h-VISA)的分离检测方法,提高临床诊断率。方法选择2010年3月-2013年3月住院患者血流感染标本中金黄色葡萄球菌50株,采用简易菌群分析法筛选h-VISA,筛选阳性后检测耐甲氧西林金黄色葡萄球菌(MRSA)对万古霉素的MIC值。结果全部50株试验菌株中共有2株在4μg/ml万古霉素的M-H培养基培养48h后生长频率≥10-6,且在不含万古霉素的M-H平板上培养9代后MIC值仍能保持在中介耐药范围内,判定为h-VISA,检出率为4.0%。结论系统地监测h-VISA的流行情况,选择有效的检测方法,对指导临床正确使用万古霉素,有效控制h-VISA的传播有重要意义。 OBJECTIVE To explore the isolation and detection of the heterogeneous vancomycin‐intermediate Staph‐ylococcus aureus (h‐VISA) so as to raise the rate of clinical diagnosis .METHODS A total of 50 strains of Staphy‐lococcus aureus were isolated from the specimens of patients with bloodstream infections who were hospitalized from Mar 2010 to Mar 2013 ,then a simple flora analysis method was employed to screen out the h‐VISA strains , and the MICs of vancomycin to methicillin‐resistant Staphylococcus aureus (MRSA) strains were determined after the positive screening .RESULTS Among all the 50 test strains ,there were 2 strains with the growing frequency of 10-6 after they were cultured in the 4μg/ml vancomycin of M‐H medium for 48 hours ,the MICs maintained in the intermediate and resistance range after 9 generations of culture in the M‐H plate without containing vancomycin , then the strains were identified as the h‐VISA strains with the detection rate of 4 .0% .CONCLUSION It is of great significance in the effective control of spread of h‐VISA to systematically monitor the prevalence of h‐VISA , choose effective detection method ,and reasonably use vancomycin .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第24期6084-6085,6093,共3页 Chinese Journal of Nosocomiology
基金 河南省卫生厅专项基金资助项目(HW-2010B-019) 河南省郑州市科技基金资助项目(083SGYS33238)
关键词 万古霉素 异质性中介 金黄色葡萄球菌 Vancomycin Heterogeneous intermediate Staphylococcus aureus
  • 相关文献

参考文献5

二级参考文献37

  • 1马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 2Steinkraus G, White R, Friedrich L. Vancomyein MIC creep in nonvaneomycin-intermediate Staphylococcus aureus (VISA), vancomycin susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother, 2007, 60: 788-794. 被引量:1
  • 3Appelbaum P. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents, 2007, 30: 398-408. 被引量:1
  • 4Song JH, Hiramatsu K, Sub JY, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother, 2004, 48: 4926-4928. 被引量:1
  • 5Maor Y, Rahav G, Belausov N, et al. Prevalence and characteristics of heteroresistant vancomycin intermediate Staphylococcus aureus bacteremia in a tertiary care center. J Clin Microbiol, 2007, 45:1511-1514. 被引量:1
  • 6Wootton M, MacGowan AP, Walsh TR, et al. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol, 2007, 45:329-332. 被引量:1
  • 7Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother, 2001,47:399-403. 被引量:1
  • 8Hiramatsu K,Aritaka N,Hanaki H,et al.Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.Lancet,1 997,350:1670-1673. 被引量:1
  • 9Finks J,Wells E,Dyke TL,et al.Vancomycin-resistant Staphylococcus auFeus,Michigan,USA,2007.Emerg Infect Dis,2009,15:943-945. 被引量:1
  • 10Hiramatsu K.Vancomycin-resistant Staphylococcus aureus:a new model of antibiotic resistance.Lancet Infect Dis,2001,1:147-155. 被引量:1

共引文献16

同被引文献45

  • 1Liu B, Liu Y, Di X, et al. Colistin and anti-Gram-positive bacte- rial agents against acinetobacter baumannii[ J]. Rev Soc Bras Med Trop, 2014,47(4) :451-456. 被引量:1
  • 2Wang B, Chai W, Ding G. The application of functional silica nanoparticles to fulfill the rapid and improved enantioselectivc cap- illary electrophoresis separation of amino acid derivatives[ J]. J Sep Sci, 2015,38(2) :332-338. 被引量:1
  • 3Soliman SM. Validated densitometrie TLC-method for the simulta- neous analysis of (R)- and (S)-citalopram and its related substances using macrocyclic antibiotic as a chiral selector: application to the determination of enantiomeric purity of escitalo- pram[J]. Int J Biomed Sei, 2012,8( 1 ) :40-50. 被引量:1
  • 4Fei J, Liu GD, Pan C J, el al. Preparation, release profiles and antibacterial properties of vancomycin-loaded Ca-P coating titanium alloy plate[J]. J Mater Sci Mater Med, 2011,22(4) :989-995. 被引量:1
  • 5Centers for Disease Control and Prevention(CDC).Staphylo-coccus aureus resistant to vancomycin-United States,2002[J].MMWR Morb Mortal Wkly Rep,2002,51(26):565-567. 被引量:1
  • 6Tiwari HK,Sen MR.Emergence of vancomycin resistant Staphy-lococcus aureus (VRSA)from a tertiary care hospital from north-ern part of India[J].BMC Infect Dis,2006,6:156. 被引量:1
  • 7Xiao YH,Giske CG,Wei ZQ,et al.Epidemiology and charac-teristics of antimicrobial resistance in China[J].Drug ResistUpdat,2011,14(4-5):236-250. 被引量:1
  • 8Wattal C,Goel N,Oberoi JK,et al.Surveillance of multidrug-resistant organisms in tertiary care hospital in Delhi,India[J].J Assoc Physicians India,2010,58:32-36. 被引量:1
  • 9Rosenthal VD,Bijie H,Maki DG,et al.International Nosoco-mial Infection Control Consortium (INICC)report,data sum-mary of 36countries,for 2004-2009[J].Am J Infect Control,2012,40(5):396-407. 被引量:1
  • 10Guh AY,Limbago BM,Kallen AJ.Epidemiology and preven-tion of carbapenem-resistant Enterobacteriaceae in the UnitedStates[J].Expert Rev Anti Infect Ther,2014,12(5):565-580. 被引量:1

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部